Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In the United States, the Food and Drug Administration (FDA) has not granted approval for retatrutide
The evidence for a class effect or a specific Tirzepatide risk remains uncertain
Groups that began at 2mg and escalated slowly had meaningfully fewer side effects than groups that started at 4mg
However, human studies are limited and generally did not find effects on appetite, calorie intake, or weight loss
US$ 29.15
US$ 26.58
US$ 28.95
US$ 28.15
US$ 23.20
US$ 21.63
